News
10-09-2025, 12:40 PM
Researchers at the Francis Crick Institute and Vividion Therapeutics have identified chemical compounds that can precisely block the interaction between the major cancer-driving gene RAS, and a key pathway for tumor growth.
More... (https://www.news-medical.net/news/20251009/Breakthrough-in-cancer-therapy-targets-key-protein-interaction-to-suppress-tumors.aspx)
More... (https://www.news-medical.net/news/20251009/Breakthrough-in-cancer-therapy-targets-key-protein-interaction-to-suppress-tumors.aspx)